Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Environ Res. 2022 Dec 30;220:115188. doi: 10.1016/j.envres.2022.115188

Fig. 3.

Fig. 3.

Map of study numbers by study types per PFAS exposure type

Pie charts depict the total number of studies on inflammation (3a) and immunosuppression (3b), which are broken down into their respective PFAS exposure and further divided into the three study types. Biomarkers that were examined in two different study types (i.e. human in vivo or animal in vitro) within the same study were counted as two separate study types. (*Indicates that the study type for PFHxS (3b) is human in vivo).